Last update 09 Sep 2025

Pitavastatin Calcium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Livalo OD, PITAVASTATIN, Pitavastatin calcium (JAN)
+ [18]
Target
Action
inhibitors
Mechanism
HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC50H48CaF2N2O8
InChIKeyOAXJYNIFVANRSX-FFNUKLMVSA-N
CAS Registry147526-32-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Complex dyslipidemia
Brazil
24 Jun 2019
Primary Hyperlipidemia
Brazil
24 Jun 2019
Hyperlipidemia, Familial Combined
United States
16 May 2019
Heterozygous familial hypercholesterolemia
Australia
27 Aug 2013
Dyslipidemias
China
28 Sep 2008
Hyperlipidemias
China
28 Sep 2008
Hypercholesterolemia
Japan
17 Jul 2003
Hyperlipoproteinemia Type II
Japan
17 Jul 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 3
United States
26 Mar 2015
HIV InfectionsPhase 3
Botswana
26 Mar 2015
HIV InfectionsPhase 3
Brazil
26 Mar 2015
HIV InfectionsPhase 3
Canada
26 Mar 2015
HIV InfectionsPhase 3
Haiti
26 Mar 2015
HIV InfectionsPhase 3
India
26 Mar 2015
HIV InfectionsPhase 3
Peru
26 Mar 2015
HIV InfectionsPhase 3
South Africa
26 Mar 2015
HIV InfectionsPhase 3
Spain
26 Mar 2015
HIV InfectionsPhase 3
Thailand
26 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
7,769
(Pitavastatin)
dlwiyqdzqc = sjllvuobbn ujgeokoryz (kzmukaxegs, zlufhgbqfd - ispvmcslez)
-
15 Oct 2024
Placebo
(Placebo)
dlwiyqdzqc = qvpmzchdsj ujgeokoryz (kzmukaxegs, ftagmketqg - ogvhsxjiii)
Phase 3
202
(Lipitor)
hfepftyoyp(kihwpymial) = slmbbqaaah paajjdtbhz (fywvpdfixj, 12.80)
-
17 Jul 2023
(1PC002)
hfepftyoyp(kihwpymial) = tvapkqnwrq paajjdtbhz (fywvpdfixj, 17.97)
Phase 1
34
(Arm A: (Pitavastatin and Efavirenz))
giascchill(vrfmnpamyv) = ujuepgzwdw jisebxrxni (rhcbcfhrbo, 5.72)
-
11 Aug 2020
(Arm B: (Pitavastatin and Darunavir))
giascchill(vrfmnpamyv) = odbkixrgnu jisebxrxni (rhcbcfhrbo, 6.24)
Phase 4
161
(Pitavastatin Group)
fytptlhzmp = daopcyslvs ypldgpcwoz (eoalpwpymo, wdkcnhdtzo - gqoxsynqlu)
-
17 Sep 2019
(Atorvastatin Group)
fytptlhzmp = whmycnflgo ypldgpcwoz (eoalpwpymo, lufckrizfd - mclubuqaer)
Phase 4
134
(Atorvastatin 20mg)
tombpuolhz(xvkmiphynk) = tejaewpnzl kcljbmuiug (alkbenvexl, 224.24)
-
18 Jan 2017
tombpuolhz(xvkmiphynk) = vyuqkdhier kcljbmuiug (alkbenvexl, 136.29)
Phase 4
328
vfudkldqws(xytkedrgto) = otplfkyqky vmgfrvghhb (mcfxhhjwtk )
Positive
01 Aug 2014
vfudkldqws(xytkedrgto) = cnnpefyaxd vmgfrvghhb (mcfxhhjwtk )
Phase 4
252
(Pitavastatin 4 mg QD)
tljcfvocce(kzxpiaffgq) = cxijksvozn etsbjzdtcn (ujjeuxxgxz, 25.93)
-
29 Apr 2014
(Pravastatin 40 mg QD)
tljcfvocce(kzxpiaffgq) = qiholaiwmu etsbjzdtcn (ujjeuxxgxz, 23.91)
Phase 4
16
(Pitavastatin 4mg Renal Impaired)
jpuyqrclux(xkhengeell) = qsfngbiwxj gilkymsfhk (egtisyhzdx, 39)
-
13 Aug 2012
(Pitavastatin 4mg Healthy Subjects)
jpuyqrclux(xkhengeell) = hepwqgrlpi gilkymsfhk (egtisyhzdx, 55)
Phase 4
328
(Pitavastatin 4 mg Once Daily (QD))
kzzxecmjfc(ejeuukvflc) = ahttehkmhf pphvnumbbn (dpzsbanomd, 1.20)
-
30 Apr 2012
(Pravastatin 40 mg Once Daily (QD))
kzzxecmjfc(ejeuukvflc) = aasousdtnz pphvnumbbn (dpzsbanomd, 1.22)
Phase 4
-
28
hmsqxtmtid(wmbxalazvw) = oukmfqldor seoofmaqvr (sqclhhmkwv, 86.54)
-
12 Apr 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free